Skip to content

CDR

WBA finalizes investment in pharmacy chain GuoDa

WBA finalizes investment in pharmacy chain GuoDa

DEERFIELD, Ill. – Walgreens Boots Alliance (WBA) today announced that, following receipt of regulatory approvals, it has completed the previously announced agreement to acquire a 40% minority stake in Sinopharm Holding GuoDa Drugstores Co., Ltd. (GuoDa), a leading retail pharmacy chain in China.

Catalent agrees to buy Juniper Pharmaceuticals

Catalent agrees to buy Juniper Pharmaceuticals

SOMERSET, N.J. – Catalent, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products,  announced that it has agreed to acquire Juniper Pharmaceuticals, including its Nottingham, U.K.-based Juniper Pharma Services division.

FDA approves Xeomin for adult patients with sialorrhea

FDA approves Xeomin for adult patients with sialorrhea

Merz North America announced  that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, in adult patients.

Eos Products hires Kang as new CMO

Eos Products hires Kang as new CMO

Eos Products, known for its iconic lip balms, shave creams, and hand & body lotions, has appointed of Soyoung Kang as chief marketing officer. In her new role, Kang is responsible for global brand strategy, communications, and innovation.

Dermira gets FDA approval for Qbrexza cloth

Dermira gets FDA approval for Qbrexza cloth

Dermira announced that the U.S. Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

Novartis seeks approval to spinoff Alcon eye care biz

Novartis seeks approval to spinoff Alcon eye care biz

Novartis today announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The planned spinoff would enable Novartis and Alcon to focus fully on their respective growth strategies.

gel-e expands its OTC label

gel-e expands its OTC label

gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (O-T-C) use of its first flowable hemostat.